PROGRESSIVE GASTROESOPHAGEAL REFLUX DISEASE IN ELDERLY PEOPLE AND RISK FACTORS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

During a 5-year follow-up of elderly patients, the likelihood of transformation of nonerosive reflux disease (NERD) to erosive reflux disease (ERD) or Barretts esophagus (BE) was 46,4 and 2,5%, respectively. ERD was a stable form in 66,8% of the patients, it transformed to NERD or BE in 26,0 and 6,4%, respectively. Lower third esophageal dysplasia occurred in 8,1% of the patients with BE during the follow-up. In the elderly patients, the leading risk factors of progressive gastroesophageal reflux disease were the absence of maintenance therapy with proton pump inhibitors (odds ratio (OR) = 6,2%; confidence interval (CI), 1,8-8,8), abdominal obesity (OR 3,1; CI, 2,3-3,9), tobacco smoking (OR 2,3; CI, 1,5-3,1); regular alcohol use (OR, 2,0; CI, 1,1-2,7).

Full Text

Restricted Access

About the authors

E. Onuchina

Irkutsk State Medical Academy for Postgraduate and Continuing Education

Email: elonu@mail.ru
MD

V. Tsukanov

Research Institute of Medical Problems of the North, Siberian Branch, Russian Academy of Medical Sciences

Email: elonu@mail.ru
Professor, MD

N. Kozlova

Ikutsk Diagnostic Center

Email: elonu@mail.ru

References

  1. Лазебник Л.Б. и др. Многоцентровое исследование «Эпидемиология гастроэзофагеальной рефлюксной болезни в России» (МЭГРЕ): первые итоги // Экспер. и клин. гастроэнтерол. - 2009; 6: 4-13.
  2. Онучина Е.В. и др. Применение препарата УДХК (Урсосан) в терапевтическом ведении больных ПБ // Экспер. и клин. гастроэнтерол. - 2010; 12: 96-101.
  3. El-Serag, H. et al. Update on the epidemiology of gastrooesophageal reflux disease: a systematic review // Gut. - 2013 Jul 13. Epub. ahead of print.
  4. Lien, H., Chang C., Yeh H. et al. Increasing prevalence of erosive esophagitis among Taiwanese aged 40 years and above: a comparison between two time periods // J. Clin. Gastroenterol. - 2009; 43 (10): 926-32.
  5. Lundell L., Dent J., Bennet J. Endoscopic assessment of oesophagitis clinical and fuctional correlates and futher validation of Los Angeles classification // Gut. - 1999; 45: 72-180.
  6. Malfertheiner P., Nocon M., Vieth M. et al. Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care-the ProGERD study // Aliment. Pharmacol. Ther. - 2012; 35 (1): 154-64.
  7. Miyamoto M., Haruma K., Kuwabara M. et al. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine // J. Gastroenterol. Hepatol. - 2007; 22 (5): 639-44.
  8. Pilotto A., Leandro G., Franceschi M. Ageing and Acid-Related Disease Study Group.Short- and long-term therapy for reflux oesophagitis in the elderly: a multicentre, placebo-controlled study with pantoprazole // Aliment. Pharmacol. Ther. -2003; 17 (11): 1399-406.
  9. Spechler S., Sharma P., Souza R. et al. American Gastroenterological Association technical review on the management of Barrett's esophagus // Gastroenterology. - 2011; 140 (3): 18-52.
  10. Vakil N., van Zanten S., Kahrilas P. et al. The Monreal Definition and Classification of gastroesophageal reflux disease: a global evidence-based consensus // Am. J. Gastroenterology. - 2006; 101: 1900-20.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2014 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies